newsfilter
← Latest News
GlobeNewswire·

CytoDyn Secures $30 Million Commitment from Yorkville Advisors

VANCOUVER, Washington, Nov. 03, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized